Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms, Experimental × Interleukin-21 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms, Experimental 1 Neoplasms 1 Lymphoma 1

Interventions

N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3 Cyclophosphamide 2 pembrolizumab 1 Vincristine 1 Prednisone 1 Interleukin-21 1 Etoposide 1 Doxorubicin 1 Bendamustine Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05296772 2023-09-06

Phase 1 First-in-human Study of JS014

Anwita Biosciences

Phase 1 Unknown

Lymphoma, Neoplasms, Neoplasms, Experimental

Data powered by HemOnc (CC BY 4.0) Colophon ⚡